SUN 01: ROTRF Symposium: Antibody-Mediated Rejection - an Ounce of Prevention is Worth a Pound of Cure
Chairs: Andrew Bradley, UK & Allan Kirk, USA
Location: MR 220 - 222, Level 2

• Humoral Immunity: Mechanisms of Graft Injury and Relationship to Cellular Immunity - William M. Baldwin, USA
• Detection and Identification of Alloantibodies circa 2010: Myths and Realities - Howard M. Gebel, USA
• The 2 Key Questions for Desensitization: Who and How? - Denis Glotz, France
• Giving the Incompatible Patient Hope with Kidney Paired Donation - Adam Bingaman, USA

SUN 02: Improving Outcomes in Kidney Transplantation: Non-HLA Antibodies and Enhanced Clinical Risk Assessment (Absorber Symposium)
Chairs: Ron Shapiro, USA
Location: MR 212 - 214, Level 2

• Introduction - Ron Shapiro, USA
• Predictors of Graft Failure in Kidney Transplant Recipients - Joseph Grinyo, Spain
• The Role of Non-HLA Antibodies on Acute Rejection - Kathryn Wood, UK
• Testing for Non-HLA Antibodies, a Clinical Approach - Anat Tambur, USA
• Summary & Closing Remarks - Ron Shapiro, USA

SUN 03: Optimal Screening of Donors and Recipients
Chairs: Elmi Muller, South Africa & Jutta Preiksaitis, Canada
Location: MR 211, Level 2

• Tuberculosis - Martina Sester, Germany
• Chagas Disease and Strongyloides - Rainaldo Bestetti, Brazil
• Use of NAT in Screening - Atul Humar, Canada
• Tricky Screening Cases and Expanding the Organ Pool - Michael Ison, USA

SUN 04: Formation, Detection and Characterization of Antibodies to Transplantation Antigens
Chairs: Susan Fuggle, UK & Noureddine Berka, Canada
Location: MR 202 - 204, Level 2

• The Immunogenicity of HLA - Ilias Doxiadis, The Netherlands
• Generation and Determinants of Cellular and Humoral Responses - Adriana Zeevi, USA
• Solid Phase Immunoassays for Antibody Detection and Quantitation - Patricia Campbell, Canada
• From Antibody Specificity to Epitope Matching - Rene Duquesnoy, USA

SUND 05: The Art of Patient Care
Chairs: Susan Chernenko, Canada & Clare Whittaker, UK
Location: MR 205 - 207, Level 2

• Nurse Led Health Promotion Clinics: A Paradigm Shift to Patient Centered Care - Joanna Routledge, UK
• Fairy Tale or Nightmare? A Patient's Story on Adherence - Paul Harden, UK

SUN 06: ELPAT: Altruistic Organ Donation to a Stranger
Chairs: Willem Weimar, The Netherlands & Bryce Kiberd, Canada
Location: MR 211, Level 2

• Altruistic Kidney and Liver Donors - Linda Wright, Canada
• "The calculating Altruist" - Leonardo de Castro, Phillipines
• Should Health Professionals Encourage Samaritan Donation? - Medard Hilhorst, The Netherlands

SUN 07: Genetically Modified Pigs For Xenotransplantation
Chairs: Peter Cowan, Australia & Jean-Paul Soulillou, France
Location: MR 212 - 214, Level 2

• Gal KO and Complement Regulators: How Far Have They Taken Us? - David Cooper, USA
• Promoters and Transgenes: What Works and What Doesn’t - Peter Cowan, Australia
• Genetic Modification of Islets: The Case for and against - Bernhard Hering, USA

SUN 08: What's New in Transplant ID
Chairs: Camille Kotton, USA & Hans Hirsch, Switzerland
Location: MR 205 - 207, Level 2

• H1N1: Impact in Solid Organ Transplantation - Deepali Kumar, Canada
• PML: Role of Rituximab and MMF - Eugene Major, USA
• Resistant Bacteria in Solid Organ Transplant - Shirish Huprikar, USA
• HHV-8 and Solid Organ Transplantation - Raymund Razonable, USA

SUN 09: "How Can We Reduce the 30 Day Mortality After Heart Transplantation?"
Chairs: Finn Gustafsson, Denmark & Heather Ross, Canada
Location: MR 220 - 222, Level 2

• Optimizing Donation and Donor Organs: Managing the Extended Donor - Marian Zembala, Poland
• Ischemia-Reperfusion Injury and Use of VAD - Darren Freed, Canada
• Perioperative CVICU Management in the Heart Transplant Recipient - Patricia Murphy, Canada

SUN 10: Proteomics  in Transplantation - A BC Proteomics Network Symposium
Chairs: Christoph Borchers, Canada & Juergen Kast, Canada
Location: MR 202 - 204, Level 2

• Innovations and Applications of Proteomics to Transplantation Biology and Medicine - Leigh Anderson, USA
• Biomarkers in Transplantation - Christoph Borchers, Canada
• From Targets to Therapies - Bruce Verchere, Canada

SUN 11: The Road to Tolerance (One Lambda Symposium)
Chair: Carl Groth, Sweden
Location: Hall A, Exhibit Level

• From Animal Models to the Clinic - David Sachs, USA
• Inducing Immune Tolerance and Chimerism after Kidney Transplantation - Samuel Strober, USA
• New Simplified Clonal Deletion Protocol with Bortezomib - HL Trivedi, India
• Paving the Road to Tolerance: DAWN versus Weaners - PI Terasaki, USA

SUN 12: TTS/IPTA Symposium on Pediatric Transplantation: Overcoming Barriers to Successful Organ Transplantation in Children
Chairs: Anne Dipchand, Canada & Richard Fine, USA
Location: MR 212 - 214, Level 2

• Obstacles to Generating Evidence for Pediatric Practice: The Need for Randomized Controlled Trials in Children - Terry Klassen, Canada
• Drug Approval in Children and the CTOT-C Program - Bill Harmon, USA
• Ethical Issues Related to Organ Donation and Transplantation in Children: A Global Perspective - Sue McDiarmid, USA

SUN 13: Xenotransplantation: From the Lab to the Clinic
Chairs: Henk Schuurman, The Netherlands & David Cooper, USA
Location: MR 202 - 204, Level 2

• Current Status of Xenotransplantation and Prospects for Clinical Application - Robin Pierson, USA
• Update on Clinical Trials in Xenotransplantation - Bob Elliott, New Zealand
• Regulatroy Issues in the Transition to Clinical Therapy - Keith Wonnacott, USA

SUN 14: Complications of Transplantation
Chairs: Alan Jardine, UK & Domingo Casadei, Argentina
Location: MR 205- 207, Level 2

• Biology and Biomarkers of Accelerated Cardiovascular Disease in Transplantation - Bengt Fellstrom, Sweden
• Prediction and Prevention of the Metabolic Syndrome in Transplantation - Bertram Kasiske, USA
• Incidence and Epidemiology of Disease Recurrence after Transplantation - Christophe Legendre, France

SUN 15: Detection and Monitoring of Antibodies Prior to Transplantation
Chairs: Phil Dyer, UK & Maria Gerbase-DeLima, Brazil
Location: MR 217 - 219, Level 2

• Antibody Monitoring for Patients on the Routine Waiting List - Phil Dyer, USA
• Determination and Use of the Calculated PRA - Sue Leffell, USA
• The Immunology Laboratory in Clinical Desensitization - Andrea Zachary, USA
• The Virtual Crossmatch and its Implications - Nancy Reinsmoen, USA

SUN 16: The Biology of Patient Care
Chairs: Clare Whittaker, UK & Norine Heywood, Canada
Location: MR 211, Level 2

• Future Directions- Genetic Markers of Rejection - Paul Keown, Canad
• Defining the Sensitized Patient: How to Identify What you Hope not to Find - Luis Hidalgo, Canada

SUN 17: Women in Transplantation
Chairs: Kathryn Wood, UK & Lee Anne Tibbles, Canada
Location: MR 212 -214, Level2

• Update on the WIT Initiative - Kathryn Wood, UK
• Women in Academic Careers: Progress and Persistent Hurdles - Judy Lieberman, USA
• Career Challenges for Young Women in Transplantation Sciences - Carla Baan, The Netherlands
• Career Challenges for Women as Clinician-Scientists in Transplantation - Susan Moffatt-Bruce, USA

SUN 18: IATDMCT Partner Symposium: Therapeutic Monitoring of Immunosuppression
Chairs: Eric Thervet, France & David Holt, UK
Location: MR 202 - 204, Level 2

• Evolving Strategies for Therapeutic Drug Monitoring - David Holt, UK
• The Contribution of Pharmacogenomics and Pharmacogenetics - Dirk Kuypers, Belgium
• Biomarkers of Pharmacological Effect - Eric Thervet, France

SUN 19: Exciting Updates in CMV
Chair: Roberta Lattes, Argentina & Raymond Razonable, USA
Location: MR 205 - 207, Level 2

• Biology and Pathogenesis - Hans-Dieter Volk, Germany
• Summary of TTS Guidelines - Camille Kotton, USA
• Immunology and Assays - Martina Sester, Germany
• Optimal Management in Lung Transplant - Marty Zamora, USA

SUN 20: Detection and Monitoring of Antibodies after Transplantation
Chairs: Robert Higgins, UK & Karen Nelson, USA
Location: MR 211, Level 2

• Update on Desensitization Strategies - James Gloor, USA
• Determinants of Antibody Formation and Titre after Transplantation - Robert Bray, USA
• Long-Term Implications of HLA Antibody - Caner Suesal, Germany
• Monitoring and Treatment of Antibody-Mediated Rejection - Robert Montgomery, USA